FDA 483 - Bora Pharmaceutical Services Inc. - January 28, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Bora Pharmaceutical Services Inc., a contract manufacturer of human drug products in Mississauga, was cited for nine observations during an FDA inspection. The inspection revealed significant deficiencies across quality control, laboratory operations, stability testing, and batch record management. Key issues include inadequate analytical testing for product release, insufficient review of production records, non-compliance with stability protocols, incomplete instrument qualifications, and poor control over labeling materials.
ID · ce4a122b-fd61-4713-b542-7d6e10c253fe